Investing Profile

Johannes Fruehauf

InvestorVC
GENERAL PARTNER at Mission BioCapital
missionbiocapital.comCambridge, Massachusetts
Photo of Johannes Fruehauf, General Partner at Mission BioCapital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Mission BioCapital General Partner
$100K - $5.0M
$1.5M
5
$275M
CompanyStageDateRound SizeTotal Raised
QurAlis
Series BMar 2023$88M
Series AMay 2020$42M
SeedNov 2018$6M
$140M
Co-investors: Amy Schulman (Polaris Partners), Jeffrey Moore (MP Healthcare Venture Management), Philip Scheltens (EQT Life Sciences), Cillian King (EQT Life Sciences), Roel Bulthuis (INKEF Capital), Laia Crespo (Sanofi Ventures), Stephen Thompson (Brandon Capital Partners)
Sentien Biotechnologies
Series AApr 2017$12M
$12M
Co-investors: Martin Heidecker (AMR Action Fund)
Sentieon
Series AApr 2014$4M
$4M
Co-investors: Martin Heidecker (AMR Action Fund)